Fair 38°
Tag:

Merck

News
CHILLING AUDIO: Local NJ Police Try To Convince Man To Drop Sword Before Shooting Him CHILLING AUDIO: Local NJ Police Try To Convince Man To Drop Sword Before Shooting Him
Chilling Audio: Local NJ Police Try To Convince Man To Drop Sword Before Shooting Him "Patrick, drop it," a New Jersey police officer says in a calm, steady voice, pleading several times with a man wielding a 3-foot sword to surrender. "Listen to me, I know you're going through some...," the officer says before his voice rises. "Patrick drop it! Get on the ground! Get on the ground!" he screams. "Drop the knife!" Then four shots are heard. The confrontation in Somerset County early last fall lasted barely a minute. About an hour and 20 minutes later, Patrick Chin, 43, was pronounced dead at Robert Wood Johnson University Hospital in New Brunswick. The comman…

SHARE

by Jerry DeMarco
News
AG: Hillsborough Man Wielded 3-Foot-Long Sword Before Being Pepper-Sprayed, Shot By Police AG: Hillsborough Man Wielded 3-Foot-Long Sword Before Being Pepper-Sprayed, Shot By Police
AG: Hillsborough Man Wielded 3-Foot-Long Sword Before Being Pepper-Sprayed, Shot By Police A Hillsborough man was holding a three-foot-long sword when he was pepper-sprayed and then shot and killed by police at his home last month, New Jersey's top law enforcement official said Monday. Five uniformed Hillsborough officers responding to a request for a welfare check went to the Piedmont Path home where Patrick Chin, 43, and his new bride lived at 4:10 p.m. Sept. 28, Acting Attorney General Andrew J. Bruck said. "When the officers arrived, they encountered Mr. Chin inside the home holding an approximately three-foot long sword," Bruck said. "During the encounter, Officer George …

SHARE

by Jerry DeMarco
News
COVID-19: NJ Drug Manufacturer Merck Says New Antiviral Drug Shows Quick Reduction In Virus COVID-19: NJ Drug Manufacturer Merck Says New Antiviral Drug Shows Quick Reduction In Virus
Covid-19: NJ Drug Manufacturer Merck Says New Antiviral Drug Shows Quick Reduction In Virus Experimental antiviral drug molnupiravir being developed by New Jersey drug manufacturer Merck with Ridgeback Bio shows a quick reduction of the infectious virus in a study among participants with early COVID-19. Molnupiravir is being tested in a Phase 2/3 trial set to be completed in May. Merck will be provided with up to  $268.8 million in funding from the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services. Associate Professor of Medicine at the University of North Carolina School of Medicine William Fis…

SHARE

by Cecilia Levine